From July, eligible Australians will be screened for lung cancer as part of the nation's first new cancer screening program ...

Recent oncology breakthroughs showcase innovative treatments and approvals, enhancing patient outcomes in CLL, RCC, NSCLC, ...

Lung cancer is one of the most common and serious types of cancer, with more than 46,000 people diagnosed with the condition every year in the UK ...

SCLC incidence in the US is projected to decline significantly through 2050, continuing a trend from 2000 to 2021. The study used SEER 17 data, showing a steady decline in SCLC cases across ...

A new report from Linn County Public Health highlights disparities in cancer diagnoses and access to care. The research, which looked at data going back to 2017 ...

The mystery deepened in the 1970s when a team of scientists entered the tomb of Polish king Casimir IV. Within weeks, 10 out ...

It was thought that Bohdan Suprun might have an infection or pneumonia, but when antibiotics didn't help him, he knew it was far more serious.

A new research paper was published in Volume 16 of Oncotarget on June 17, 2025, titled "Molecular landscape of HER2-mutated ...

AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced that the FDA had granted accelerated approval to Datroway for the treatment ...

A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...

The firm will take a different reimbursement strategy for the test than its prior owner Biocept, which stopped selling it after filing for bankruptcy in 2023.

If the air quality is poor, stay inside as much as possible and avoid fireworks.